瘤坏死因子-α 抑制胰岛素对葡萄糖吸收和内皮依赖血管扩张的刺激作用
Christian Rask-Madsen1, Helena Domínguez, Nikolaj Ihlemann
1Joslin Diabetes Center, Section on Vascular Cell Biology and Complications, One Joslin Place, Room 4504, Boston, Mass 02215, USA. christian.rask-madsen@joslin.harvard.edu
Circulation
|October 8, 2003
概括
瘤坏死因子-α (TNF-α) 显著影响胰岛素刺激的葡萄糖吸收和人类内皮功能. 这表明TNF-α有助于肌肉和血管组织的胰岛素抵抗.
科学领域:
- 人类生理学 人类生理学
- 代谢障碍 代谢障碍 代谢障碍
- 炎症 炎症是一种炎症.
背景情况:
- 炎症机制与胰岛素耐药性和动脉样硬化有关.
- 瘤坏死因子-α (TNF-α) 是一种关键的促炎细胞因子.
研究的目的:
- 调查TNF-α是否抑制人类的胰岛素刺激葡萄糖摄取.
- 为了检查TNF-alpha对胰岛素刺激的内皮功能的影响.
主要方法:
- 健康的男性志愿者接受了手臂动脉输液.
- 使用乙胆 (ACh) 和酸 (SNP) 进行了剂量反应研究.
- 同时注射胰岛素和/或TNF-alpha,以评估对葡萄糖吸收和血液流动的影响.
主要成果:
- 胰岛素刺激的前臂葡萄糖吸收增加了220%,但被TNF-alpha完全抑制.
- TNF-α显著抑制了ACH诱导的前臂血流,特别是在胰岛素输注期间.
- TNF-alpha对ACh反应的抑制可能是由减少的氧化 (NO) 生产所介导的.
结论:
- TNF-alpha在人类肌肉中胰岛素抵抗的发展中发挥着作用.
- TNF-α有助于血管功能障碍,这表明它在动脉样硬化发展中起着作用.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Hormones Regulating Blood Glucose
7.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
Insulin: The Receptor and Signaling Pathways
6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36


